What medications can cause 2nd degree heart block?

Medications That Can Cause Second-Degree Heart Block

Beta-blockers, calcium channel blockers, digoxin, and certain antiarrhythmic drugs are the most common medications that can cause second-degree heart block. These medications affect cardiac conduction primarily through their action on the atrioventricular (AV) node or the His-Purkinje system.

Common Medications That Cause 2nd Degree AV Block

Beta-Blockers

• All beta-blockers can cause second-degree heart block by slowing conduction through the AV node 1
• Specific agents include:
  • Atenolol 1, 2
  • Metoprolol (both tartrate and succinate forms) 1
  • Nadolol 1
  • Propranolol 1
• Beta-blockers are particularly problematic in patients with pre-existing conduction system disease 3

Calcium Channel Blockers (Non-dihydropyridine)

• Diltiazem and verapamil are potent AV nodal blocking agents 1
• These medications slow conduction through the AV node and can precipitate second-degree AV block in susceptible individuals 1
• The risk is higher when these medications are combined with other drugs that affect cardiac conduction 1

Cardiac Glycosides

• Digoxin can cause various degrees of heart block, including second-degree AV block 1, 4
• Digoxin toxicity commonly manifests as cardiac arrhythmias including second-degree heart block 4
• The risk increases with higher serum concentrations and in patients with electrolyte abnormalities (particularly hypokalemia) 4

Mechanism of Drug-Induced AV Block

• Most drug-induced second-degree AV block occurs at the level of the AV node (Mobitz type I/Wenckebach) 5, 6
• Medications primarily affect cardiac conduction by:
  • Decreasing automaticity in the SA node 7
  • Slowing conduction through the AV node 8, 9
  • Prolonging refractory periods in cardiac tissue 7
• Beta-blockers and calcium channel blockers primarily affect the AV node by blocking sympathetic tone and calcium channels respectively 3, 9

Risk Factors for Developing Drug-Induced AV Block

• Pre-existing conduction system disease 5, 10
• Advanced age 10
• Electrolyte abnormalities, particularly hypokalemia or hypomagnesemia 7
• Concurrent use of multiple medications that affect cardiac conduction 10
• Higher doses of AV nodal blocking medications 4, 10

Clinical Considerations

• Drug-induced AV block may be temporary and resolve with discontinuation of the offending medication in approximately 41% of cases 10
• However, in many patients (56%), AV block recurs even after drug discontinuation, suggesting underlying conduction system disease 10
• Only about 15% of AV block occurring during therapy with beta-blockers or calcium channel blockers is truly caused by the medications alone 10
• Bradycardia associated with second-degree heart block may be asymptomatic or cause symptoms such as dizziness, lightheadedness, or syncope 9

Management of Drug-Induced AV Block

• For symptomatic second-degree heart block, the offending medication should be reduced or discontinued 8, 9
• Consider possible drug interactions that may potentiate AV block 9
• For beta-blocker induced AV block:
  • Atropine can be used for acute management 2
  • In refractory cases, isoproterenol or temporary pacing may be required 2
• Permanent pacemaker implantation may be necessary if AV block persists despite drug discontinuation, particularly for infranodal block 6

Important Caveats

• A 2:1 AV block cannot be classified as Mobitz type I or II based on ECG appearance alone 11
• The anatomical site of block (AV nodal vs. infranodal) is more important for prognosis than the ECG classification 5, 6
• Infranodal block (typically Mobitz type II) has a higher risk of progression to complete heart block 5
• Drug-induced AV block may unmask underlying conduction system disease rather than being the sole cause 10

Remember that patients with pre-existing conduction abnormalities should be monitored closely when starting medications known to affect cardiac conduction, particularly beta-blockers, calcium channel blockers, and digoxin 1, 9, 4.